These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 12691838)
21. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release. Leysen JE; Gommeren W; Janssen PA Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715 [TBL] [Abstract][Full Text] [Related]
22. Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](+/-)DOI and [3H]ketanserin. López-Giménez JF; Mengod G; Palacios JM; Vilaró MT Eur J Neurosci; 1999 Oct; 11(10):3761-5. PubMed ID: 10564383 [TBL] [Abstract][Full Text] [Related]
23. Platelet 3H ketanserin binding in tension-type headache. Shukla R; Husain M; Tandon R; Khanna VK; Nag D; Dikshit M; Srimal RC; Seth PK Headache; 2003 Feb; 43(2):103-8. PubMed ID: 12558763 [TBL] [Abstract][Full Text] [Related]
24. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease. Holmes C; McCulley M; Nicoll JA; Alder JT; Chen CP; Francis PT Neurosci Lett; 2007 Jun; 420(1):58-60. PubMed ID: 17481814 [TBL] [Abstract][Full Text] [Related]
25. Platelet 3H ketanserin binding in migraine. Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383 [TBL] [Abstract][Full Text] [Related]
26. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex. Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336 [TBL] [Abstract][Full Text] [Related]
27. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Branchek T; Adham N; Macchi M; Kao HT; Hartig PR Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697 [TBL] [Abstract][Full Text] [Related]
28. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors. Scandroglio A; Monferini E; Borsini F Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720 [TBL] [Abstract][Full Text] [Related]
29. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007 [TBL] [Abstract][Full Text] [Related]
30. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes. Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696 [TBL] [Abstract][Full Text] [Related]
31. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Burris KD; Sanders-Bush E Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397 [TBL] [Abstract][Full Text] [Related]
32. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide. Gross-Isseroff R; Salama D; Israeli M; Biegon A Brain Res; 1990 Jan; 507(2):208-15. PubMed ID: 2337761 [TBL] [Abstract][Full Text] [Related]
34. Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes. Israilova M; Suzuki F; Tanaka T; Nagatomo T; Taniguchi T; Muramatsu I Pharmacology; 2002 May; 65(2):69-73. PubMed ID: 11937776 [TBL] [Abstract][Full Text] [Related]
35. Specific binding of [3H]ketanserin to hypothalamus membranes of juvenile rainbow trout, Oncorhynchus mykiss. Agrawal SM; Omeljaniuk RJ Can J Physiol Pharmacol; 2000 Jan; 78(1):58-66. PubMed ID: 10741761 [TBL] [Abstract][Full Text] [Related]
36. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia. Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947 [TBL] [Abstract][Full Text] [Related]
37. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Burnet PW; Eastwood SL; Harrison PJ Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117 [TBL] [Abstract][Full Text] [Related]
38. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites. Leysen JE; Van Gompel P; Gommeren W J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521 [TBL] [Abstract][Full Text] [Related]
39. The affinity of antipsychotic drugs to dopamine and serotonin 5-HT Tollens F; Gass N; Becker R; Schwarz AJ; Risterucci C; Künnecke B; Lebhardt P; Reinwald J; Sack M; Weber-Fahr W; Meyer-Lindenberg A; Sartorius A Eur Neuropsychopharmacol; 2018 Sep; 28(9):1035-1046. PubMed ID: 30006253 [TBL] [Abstract][Full Text] [Related]
40. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Kuroki T; Nagao N; Nakahara T Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]